Adage Capital Partners’s Collegium Pharmaceutical COLL Stock Holding History

Adage Capital Partners’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-190,000	Closed	-$4.41M	–	935
2022 Q4	$4.41M	Sell	190,000 -25,000	-12%	-$504K	0.01%	764
2022 Q3	$3.44M	Sell	215,000 -25,000	-10%	-$441K	0.01%	819
2022 Q2	$4.25M	Buy	+240,000	New	+$4.04M	0.01%	817
2016 Q2	–	Sell	-490,104	Closed	-$8.89M	–	687
2016 Q1	$8.89M	Sell	490,104 -350,000	-42%	-$6.36M	0.02%	543
2015 Q4	$23.1M	Sell	840,104 -166,908	-17%	-$3.52M	0.06%	341
2015 Q3	$22.3M	Buy	1,007,012 +148,921	+17%	+$2.69M	0.06%	358
2015 Q2	$15.3M	Buy	+858,091	New	+$14.8M	0.04%	472

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Adage Capital Partners's COLL Position: Q1 2023 in Review

Adage Capital Partners sold out of Collegium Pharmaceutical (COLL) in Q1 2023, closing a stake of 190,000 shares — an estimated $4.41M sold.

Adage Capital Partners first reported a position in COLL in Q2 2015 and held it in 7 quarters. The position peaked at $23.1M in Q4 2015. 198 funds tracked by Wall St. Rank hold COLL as of Q1 2023.

Adage Capital Partners reported no remaining Collegium Pharmaceutical position as of Q1 2023 after selling out during the quarter.
Adage Capital Partners sold 190,000 Collegium Pharmaceutical shares in Q1 2023, an estimated $4.41M.
Adage Capital Partners first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 7 quarters.
Adage Capital Partners's Collegium Pharmaceutical position peaked at $23.1M in Q4 2015.
198 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2023.

Based on Adage Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.